Company Overview and News

 
Akzo Nobel India Limited - Updates

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Reply to Clarification- Financial results

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Market Live: Sensex up 275 pts, Nifty inches towards 10,900 as BJP leads in Karnataka

2018-05-15 moneycontrol
Emkay on CPI Inflation: After a softening trend of inflation in Q4FY18, Apr’18 witnessed a sharp reversal in overall inflation, both at wholesale and retail levels. CPI inflation rose to 4.6 percent while WPI too picked up momentum with 3.2 percent print.

 
Akzo Nobel India Limited - Clarification - Financial Results

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Dividend

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Outcome of Board Meeting

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Press Release

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Outcome of Board Meeting

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Akzo Nobel India Limited - Financial Result Updates

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Closing Bell: Sensex, Nifty end flat ahead of Fed meet outcome; midcaps dive

2018-05-02 moneycontrol
3:30 pm Market Closing: The market closed flat after rangebound session, as investors await Federal Reserve meeting outcome due tonight.

 
Market Live: Nifty consolidates ahead of Fed rate decision; Kotak Bank off day#39;s high

2018-05-02 moneycontrol
2:54 pm Market Update: The market remained rangebound amid March quarter earnings reports, and ahead of Federal Reserve meeting outcome tonight.

 
Market Live: Sensex up over 100 pts; HDFC twins, RIL, ITC, Kotak Bank lead

2018-05-02 moneycontrol
2:01 pm Europe Update: European markets were higher as investors kept their focus on earnings and monitored an upcoming Federal Reserve meeting.

 
Market Live: Nifty ranged, Kotak Bank jumps 5%; Metal, IT, PSU Bank indices dive

2018-05-02 moneycontrol
11:55 am Manufacturing PMI: Indian factory growth accelerated in April on strong domestic demand and output, a business survey showed, while price pressures were subdued in a comforting sign for the central bank as it seeks to temper inflation without hurting the economy.

 
Market Live: Sensex consolidates; IT stocks under pressure, ICICI Bank extends losses

2018-05-02 moneycontrol
10:43 am Market Update: The market continued to be rangebound amid weak Asian cues. Technology, FMCG, metals stocks and ICICI Bank were under pressure while auto stocks, Reliance Industries, Kotak Mahindra Bank and HDFC Bank continued to support the market.

 
Market Live: Sensex consolidates; April sales lifts auto stocks, HCL Tech top loser

2018-05-02 moneycontrol
9:45 am Order Win: NBCC share price gained 1 percent after it has received letter of appointment from Ministry of External Affairs, Govt. of India for the construction of Mahatma Gandhi Convention Centres (MGCC) in nine (9) African Countries namely Niger, Uganda, Malawi, Zambia, Liberia, Gambia, Burkina Faso, Togo and Gabon amounting Rs 2,000 crore.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...